Breast Cancer Research in China

China is a major contributor to global Breast Cancer research, with 1,090 active researchers publishing in this field across 323 institutions in 99 cities. The country's research ecosystem in breast cancer combines strong institutional support, robust funding mechanisms, and collaborative research networks.

Research activity in Breast Cancer across China spans fundamental investigations into triple-negative breast cancer to translational studies aimed at clinical applications. The distributed research community across Beijing, Shanghai, Guangzhou and other cities creates diverse opportunities for researchers at all career stages.

China's research institutions have established strong programs in Breast Cancer, with many achieving international recognition for their contributions to breast cancer research. These institutions offer:

**Research Infrastructure**: State-of-the-art facilities for triple-negative breast cancer research, including specialized equipment, core facilities, and technical expertise. Many institutions have made significant investments in infrastructure specifically for Breast Cancer research.

**Collaborative Environment**: Strong institutional support for interdisciplinary collaboration brings together experts in breast cancer, triple-negative breast cancer, HER2, creating rich research environments where innovation thrives.

**Training Programs**: Comprehensive training opportunities for early-career researchers, including structured postdoctoral programs, workshops, and mentorship initiatives focused on breast cancer research.

**Funding Opportunities**: Access to national and international funding sources, with many institutions providing bridge funding, startup packages, and internal grants to support Breast Cancer research.

The 323 institutions conducting Breast Cancer research in China range from large comprehensive universities with broad biomedical programs to specialized research institutes focused on specific aspects of breast cancer.

Researchers interested in Breast Cancer positions in China will find a range of opportunities and funding mechanisms:

**Postdoctoral Fellowships**: Many institutions offer postdoctoral positions in breast cancer research, often with competitive salaries and benefits. National fellowship programs may also provide funding for international researchers to conduct Breast Cancer research in China.

**Research Grants**: Funding agencies in China support triple-negative breast cancer research through various grant mechanisms, from early-career awards to large collaborative grants. International researchers often have access to these funding opportunities.

**Industry Partnerships**: Growing interest from biotechnology and pharmaceutical companies has created partnerships with academic institutions, providing additional research funding and career opportunities in HER2.

**Career Development**: Many institutions in China provide structured career development support for researchers, including grant writing assistance, mentorship programs, and professional development workshops.

Explore the cities and institutions below to discover specific opportunities in Breast Cancer research across China.